Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016
Cecily Campbell, Lauren Canary, Nicole Smith, et al.
MMWR Morbidity and Mortality Weekly Report (2017) Vol. 66, Iss. 18, pp. 465-469
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma
Lung‐Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, et al.
American Society of Clinical Oncology Educational Book (2018), Iss. 38, pp. 262-279
Closed Access | Times Cited: 209
Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
Eli S. Rosenberg, Elizabeth M. Rosenthal, Eric W. Hall, et al.
JAMA Network Open (2018) Vol. 1, Iss. 8, pp. e186371-e186371
Open Access | Times Cited: 164
What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats
John W. Ward, Alan R. Hinman
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 297-310
Closed Access | Times Cited: 100
Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C
Asher J Schranz, Jessica L. Barrett, Christopher B. Hurt, et al.
Current HIV/AIDS Reports (2018) Vol. 15, Iss. 3, pp. 245-254
Open Access | Times Cited: 96
Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016
Heather Bradley, Eric W. Hall, Elizabeth M. Rosenthal, et al.
Hepatology Communications (2020) Vol. 4, Iss. 3, pp. 355-370
Open Access | Times Cited: 79
Trends in the Mortality of Hepatocellular Carcinoma in the United States
Eliza W. Beal, Dmitry Tumin, Ali Kabir, et al.
Journal of Gastrointestinal Surgery (2017) Vol. 21, Iss. 12, pp. 2033-2038
Closed Access | Times Cited: 66
The Hepatitis C Virus Care Continuum: Linkage to Hepatitis C Virus Care and Treatment Among Patients at an Urban Health Network, Philadelphia, PA
Catelyn Coyle, Anne C. Moorman, Tyler S. Bartholomew, et al.
Hepatology (2019) Vol. 70, Iss. 2, pp. 476-486
Open Access | Times Cited: 65
State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019
Marcelo H. Fernández-Viña, Nadya Prood, Adam Herpolsheimer, et al.
Public Health Reports (2020) Vol. 135, Iss. 1_suppl, pp. 128S-137S
Open Access | Times Cited: 53
Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma
Eliza W. Beal, Dmitry Tumin, Demetrios Moris, et al.
HepatoBiliary Surgery and Nutrition (2018) Vol. 7, Iss. 4, pp. 270-276
Open Access | Times Cited: 55
The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes
David A. Axelrod, Mark A. Schnitzler, Tarek Alhamad, et al.
American Journal of Transplantation (2018) Vol. 18, Iss. 10, pp. 2473-2482
Open Access | Times Cited: 49
The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018
Deborah Holtzman, Alice Asher, Sarah Schillie
American Journal of Public Health (2021) Vol. 111, Iss. 5, pp. 949-955
Open Access | Times Cited: 34
Risk Factors for Perinatal Transmission of Hepatitis C Virus
Mona Prasad, George R. Saade, Rebecca G. Clifton, et al.
Obstetrics and Gynecology (2023) Vol. 142, Iss. 3, pp. 449-456
Open Access | Times Cited: 14
Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the global burden of disease study 2021
Jiahao Jiang, Zhiqin Xie, Qingbin Wang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs
Carolina Barbosa, Hannah Fraser, Thomas J. Hoerger, et al.
Addiction (2019) Vol. 114, Iss. 12, pp. 2267-2278
Open Access | Times Cited: 37
Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic
Miguel Malespin, Ciel Harris, Ozdemir Kanar, et al.
Annals of Hepatology (2019) Vol. 18, Iss. 2, pp. 304-309
Open Access | Times Cited: 30
Barriers to using new needles encountered by rural Appalachian people who inject drugs: implications for needle exchange
Stephen M. Davis, Álfgeir L. Kristjánsson, Danielle M. Davidov, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 30
Qualitative case study of needle exchange programs in the Central Appalachian region of the United States
Stephen M. Davis, Danielle M. Davidov, Álfgeir L. Kristjánsson, et al.
PLoS ONE (2018) Vol. 13, Iss. 10, pp. e0205466-e0205466
Open Access | Times Cited: 30
Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV Prevention
Pedro Mateu‐Gelabert, Honoria Guarino, Kelly Quinn, et al.
Current HIV/AIDS Reports (2018) Vol. 15, Iss. 4, pp. 324-335
Open Access | Times Cited: 28
‘Treat my whole person, not just my condition’: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs
Judith I. Tsui, Michael P. Barry, Elizabeth J. Austin, et al.
Addiction Science & Clinical Practice (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 20
Are we underestimating the quality of aviremic hepatitis C–positive kidneys? Time to reconsider
Lena Sibulesky, Catherine E. Kling, Christopher D. Blosser, et al.
American Journal of Transplantation (2018) Vol. 18, Iss. 10, pp. 2465-2472
Open Access | Times Cited: 26
Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016–2017
Kathleen N. Ly, Arialdi M. Miniño, Stephen J. Liu, et al.
Clinical Infectious Diseases (2019) Vol. 71, Iss. 5, pp. 1149-1160
Open Access | Times Cited: 25
Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015
Winston E. Abara, Lindsay Trujillo, Dita Broz, et al.
The Journal of Infectious Diseases (2019) Vol. 220, Iss. 3, pp. 377-385
Open Access | Times Cited: 23
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England
Eric Romo, Abby E. Rudolph, Thomas J. Stopka, et al.
Addiction Science & Clinical Practice (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Accurate spatiotemporal mapping of drug overdose deaths by machine learning of drug-related web-searches
David S. Campo, J. Walker Gussler, Amanda Sue, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243622-e0243622
Open Access | Times Cited: 19
Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment Using Health Economic Modeling
Jagpreet Chhatwal, Qiushi Chen, Rakesh Aggarwal
Infectious Disease Clinics of North America (2018) Vol. 32, Iss. 2, pp. 461-480
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top